Quantification of Circulating HBV RNA Expressed from Intrahepatic cccDNA in Untreated and NUC Treated Patients with Chronic Hepatitis B

Archive ouverte

Testoni, Barbara | Scholtès, Caroline | Plissonnier, Marie-Laure | Paturel, Alexia | Berby, Françoise | Fachetti, Floriana | Villeret, François | Degasperi, Elisabetta | Scott, Beth | Hamilton, Aaron | Heil, Marintha | Lampertico, Pietro | Levrero, Massimo | Zoulim, Fabien

Edité par CCSD ; BMJ Publishing Group -

International audience. Objective: A convenient, reproducible biomarker of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) transcriptional activity is lacking. We measured circulating HBV RNA (cirB-RNA) in untreated and nucleos(t)ide analogues (NUC) treated chronic hepatitis B (CHB) patients to define its correlation with intrahepatic viral markers and HBV core-related antigen (HBcrAg).Design: Paired liver biopsy and serum samples were collected from 122 untreated and 30 NUC-treated CHB patients. We measured cirB-RNA, HBV DNA, hepatitis B surface antigen (HBsAg), HBcrAg and alanine aminotransferase levels. cirB-RNA was quantified using an investigational HBV RNA assay for use on the cobas 6800 system. The test detects a region spanning the HBV canonical polyadenylation site. cccDNA and 3.5 kb RNA in liver tissue were assessed by quantitative PCR and droplet digital PCR.Results: cirB-RNA was detectable in 100% of HBeAg(+) chronic hepatitis (CH), 57% and 14% of HBeAg(-) CH and chronic infection untreated patients and 47% of NUC-treated patients. cirB-RNA undetectability was associated with lower intrahepatic cccDNA transcriptional activity, as well as serum HBcrAg, but no significant differences in HBsAg, in both untreated and treated patients. In untreated HBeAg(-) patients, cirB-RNA correlated with intrahepatic 3.5 kb RNA and cccDNA transcriptional activity, serum HBV DNA and HBcrAg, but not with HBsAg or total cccDNA levels. Combined undetectability of both cirB-RNA and HBcrAg detection in untreated HBeAg(-) patients identified a subgroup with the lowest levels of intrahepatic transcriptionally active cccDNA.Conclusion: Our results support the usefulness of quantification of circulating HBV RNA expressed from cccDNA as an indicator of intrahepatic active viral reservoir in both untreated and NUC-treated CHB patients.

Suggestions

Du même auteur

Performance of the cobas® HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients

Archive ouverte | Scholtès, Caroline | CCSD

International audience

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis

Archive ouverte | Villeret, François | CCSD

International audience. Background & Aims: Prophylaxis with nucleos(t)ide analogues (NUCs) and hepatitis B immunoglobulin (HBIG) has decreased the rate of HBV recurrence after orthotopic liver transplantation (OLT),...

A molecular standard for circulating HBV RNA detection and quantification assays in patients with chronic hepatitis B

Archive ouverte | Paturel, Alexia | CCSD

International audience. Background & aims: Circulating HBV RNAs have been proposed as a biomarker that reflects the transcriptional activity of covalently closed circular DNA (cccDNA) and may help to evaluate HB...

Chargement des enrichissements...